Trial intelligence / Profile preview

Zintas (zinc) for hypozincemia-associated olfactory dysfunction

jRCT1031250332Recruiting

Start
Dec 2025
Modality
Small Molecules
Countries
1
01

Overview

Open-label, single-arm trial of zinc in Olfactory disorder and zinc deficiency. Primary endpoint: Primary: correlation between serum zinc level at first checkpoint and change in baseline olfactory acuity from start to first checkpoint. Started Dec 2025; status: recruiting.

02

Drugs

zinc
03

Conditions

Olfactory disorderzinc deficiency

Beyond the preview

Go deeper on jRCT1031250332.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on jRCT1031250332.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call